← Open Payments lookup

MATTHEW DAY: Open Payments

NPI 1245017375 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $379 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
Amgen Inc.14$173
ANI Pharmaceuticals, Inc.3$71
Otsuka America Pharmaceutical, Inc.3$67
Calliditas Therapeutics US Inc.2$45
GlaxoSmithKline, LLC.2$42
Alexion Pharmaceuticals, Inc.2$35
Novartis Pharmaceuticals Corporation2$31
Lilly USA, LLC1$21
Vifor Pharma, Inc.1$21
Actelion Pharmaceuticals US, Inc.1$17

Products named: TAVNEOS, KRYSTEXXA, PURIFIED CORTROPHIN GEL, JYNARQUE, TARPEYO, BENLYSTA, ULTOMIRIS, MOUNJARO.

Industry payments across ID — which companies pay providers there.